![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ACBD3 |
Gene summary for ACBD3 |
![]() |
Gene information | Species | Human | Gene symbol | ACBD3 | Gene ID | 64746 |
Gene name | acyl-CoA binding domain containing 3 | |
Gene Alias | GCP60 | |
Cytomap | 1q42.12 | |
Gene Type | protein-coding | GO ID | GO:0006629 | UniProtAcc | A0A024R3P9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
64746 | ACBD3 | P19T-E | Human | Esophagus | ESCC | 5.10e-03 | 2.40e-01 | 0.1662 |
64746 | ACBD3 | P20T-E | Human | Esophagus | ESCC | 3.76e-13 | 3.28e-01 | 0.1124 |
64746 | ACBD3 | P21T-E | Human | Esophagus | ESCC | 4.68e-19 | 3.51e-01 | 0.1617 |
64746 | ACBD3 | P22T-E | Human | Esophagus | ESCC | 1.19e-20 | 3.74e-01 | 0.1236 |
64746 | ACBD3 | P23T-E | Human | Esophagus | ESCC | 7.59e-38 | 8.83e-01 | 0.108 |
64746 | ACBD3 | P24T-E | Human | Esophagus | ESCC | 2.58e-11 | 1.93e-01 | 0.1287 |
64746 | ACBD3 | P26T-E | Human | Esophagus | ESCC | 1.89e-27 | 4.41e-01 | 0.1276 |
64746 | ACBD3 | P27T-E | Human | Esophagus | ESCC | 3.78e-10 | 2.31e-01 | 0.1055 |
64746 | ACBD3 | P28T-E | Human | Esophagus | ESCC | 1.94e-46 | 1.05e+00 | 0.1149 |
64746 | ACBD3 | P30T-E | Human | Esophagus | ESCC | 2.69e-23 | 8.65e-01 | 0.137 |
64746 | ACBD3 | P31T-E | Human | Esophagus | ESCC | 1.34e-20 | 3.57e-01 | 0.1251 |
64746 | ACBD3 | P32T-E | Human | Esophagus | ESCC | 1.15e-14 | 2.09e-01 | 0.1666 |
64746 | ACBD3 | P36T-E | Human | Esophagus | ESCC | 3.70e-13 | 2.83e-01 | 0.1187 |
64746 | ACBD3 | P37T-E | Human | Esophagus | ESCC | 1.28e-09 | 2.30e-01 | 0.1371 |
64746 | ACBD3 | P38T-E | Human | Esophagus | ESCC | 3.67e-03 | 1.26e-01 | 0.127 |
64746 | ACBD3 | P39T-E | Human | Esophagus | ESCC | 1.48e-21 | 3.11e-01 | 0.0894 |
64746 | ACBD3 | P40T-E | Human | Esophagus | ESCC | 8.35e-19 | 6.05e-01 | 0.109 |
64746 | ACBD3 | P42T-E | Human | Esophagus | ESCC | 1.12e-19 | 3.05e-01 | 0.1175 |
64746 | ACBD3 | P44T-E | Human | Esophagus | ESCC | 1.45e-14 | 2.52e-01 | 0.1096 |
64746 | ACBD3 | P47T-E | Human | Esophagus | ESCC | 3.36e-23 | 3.99e-01 | 0.1067 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00066944 | Breast | IDC | steroid biosynthetic process | 25/1434 | 173/18723 | 1.56e-03 | 1.56e-02 | 25 |
GO:000669411 | Breast | DCIS | steroid biosynthetic process | 23/1390 | 173/18723 | 4.63e-03 | 3.52e-02 | 23 |
GO:00066946 | Esophagus | ESCC | steroid biosynthetic process | 98/8552 | 173/18723 | 2.34e-03 | 1.03e-02 | 98 |
GO:000820211 | Liver | Cirrhotic | steroid metabolic process | 143/4634 | 319/18723 | 2.79e-15 | 3.18e-13 | 143 |
GO:00066941 | Liver | Cirrhotic | steroid biosynthetic process | 77/4634 | 173/18723 | 1.02e-08 | 3.91e-07 | 77 |
GO:00082022 | Liver | HCC | steroid metabolic process | 188/7958 | 319/18723 | 1.96e-09 | 5.63e-08 | 188 |
GO:00066942 | Liver | HCC | steroid biosynthetic process | 104/7958 | 173/18723 | 2.13e-06 | 2.91e-05 | 104 |
GO:00066945 | Oral cavity | OSCC | steroid biosynthetic process | 89/7305 | 173/18723 | 5.77e-04 | 3.30e-03 | 89 |
GO:00082024 | Oral cavity | OSCC | steroid metabolic process | 146/7305 | 319/18723 | 7.78e-03 | 2.85e-02 | 146 |
GO:000669412 | Oral cavity | LP | steroid biosynthetic process | 58/4623 | 173/18723 | 5.44e-03 | 3.31e-02 | 58 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0513243 | Breast | DCIS | Salmonella infection | 55/846 | 249/8465 | 8.71e-09 | 1.87e-07 | 1.38e-07 | 55 |
hsa0513253 | Breast | DCIS | Salmonella infection | 55/846 | 249/8465 | 8.71e-09 | 1.87e-07 | 1.38e-07 | 55 |
hsa0513222 | Liver | Cirrhotic | Salmonella infection | 121/2530 | 249/8465 | 2.47e-10 | 5.13e-09 | 3.16e-09 | 121 |
hsa0513232 | Liver | Cirrhotic | Salmonella infection | 121/2530 | 249/8465 | 2.47e-10 | 5.13e-09 | 3.16e-09 | 121 |
hsa0513242 | Liver | HCC | Salmonella infection | 178/4020 | 249/8465 | 5.90e-15 | 1.98e-13 | 1.10e-13 | 178 |
hsa0513252 | Liver | HCC | Salmonella infection | 178/4020 | 249/8465 | 5.90e-15 | 1.98e-13 | 1.10e-13 | 178 |
hsa0513216 | Lung | IAC | Salmonella infection | 52/1053 | 249/8465 | 9.46e-05 | 1.28e-03 | 8.50e-04 | 52 |
hsa0513217 | Lung | IAC | Salmonella infection | 52/1053 | 249/8465 | 9.46e-05 | 1.28e-03 | 8.50e-04 | 52 |
hsa0513223 | Lung | AIS | Salmonella infection | 50/961 | 249/8465 | 3.47e-05 | 5.62e-04 | 3.59e-04 | 50 |
hsa0513233 | Lung | AIS | Salmonella infection | 50/961 | 249/8465 | 3.47e-05 | 5.62e-04 | 3.59e-04 | 50 |
hsa0513230 | Oral cavity | OSCC | Salmonella infection | 174/3704 | 249/8465 | 2.67e-17 | 1.49e-15 | 7.58e-16 | 174 |
hsa05132114 | Oral cavity | OSCC | Salmonella infection | 174/3704 | 249/8465 | 2.67e-17 | 1.49e-15 | 7.58e-16 | 174 |
hsa05132210 | Oral cavity | LP | Salmonella infection | 128/2418 | 249/8465 | 1.17e-14 | 2.79e-13 | 1.80e-13 | 128 |
hsa0513238 | Oral cavity | LP | Salmonella infection | 128/2418 | 249/8465 | 1.17e-14 | 2.79e-13 | 1.80e-13 | 128 |
hsa0513245 | Oral cavity | EOLP | Salmonella infection | 78/1218 | 249/8465 | 3.66e-12 | 2.37e-10 | 1.40e-10 | 78 |
hsa0513255 | Oral cavity | EOLP | Salmonella infection | 78/1218 | 249/8465 | 3.66e-12 | 2.37e-10 | 1.40e-10 | 78 |
hsa0513228 | Prostate | BPH | Salmonella infection | 99/1718 | 249/8465 | 7.26e-13 | 1.50e-11 | 9.27e-12 | 99 |
hsa05132113 | Prostate | BPH | Salmonella infection | 99/1718 | 249/8465 | 7.26e-13 | 1.50e-11 | 9.27e-12 | 99 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ACBD3 | SNV | Missense_Mutation | c.1042N>C | p.Glu348Gln | p.E348Q | Q9H3P7 | protein_coding | tolerated(0.13) | possibly_damaging(0.643) | TCGA-A8-A0A7-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ACBD3 | SNV | Missense_Mutation | c.676G>A | p.Glu226Lys | p.E226K | Q9H3P7 | protein_coding | tolerated(0.09) | possibly_damaging(0.899) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
ACBD3 | SNV | Missense_Mutation | c.1568G>C | p.Arg523Thr | p.R523T | Q9H3P7 | protein_coding | deleterious(0) | probably_damaging(0.983) | TCGA-D8-A1JN-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | anastrozolum | SD | |
ACBD3 | SNV | Missense_Mutation | novel | c.634G>C | p.Glu212Gln | p.E212Q | Q9H3P7 | protein_coding | tolerated(0.05) | probably_damaging(0.932) | TCGA-PE-A5DE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR |
ACBD3 | deletion | Frame_Shift_Del | novel | c.327delA | p.Lys109AsnfsTer2 | p.K109Nfs*2 | Q9H3P7 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | ||
ACBD3 | SNV | Missense_Mutation | novel | c.580N>C | p.Glu194Gln | p.E194Q | Q9H3P7 | protein_coding | tolerated(0.1) | probably_damaging(0.932) | TCGA-C5-A8XK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
ACBD3 | SNV | Missense_Mutation | rs752822487 | c.1333G>A | p.Val445Met | p.V445M | Q9H3P7 | protein_coding | deleterious(0) | probably_damaging(0.986) | TCGA-AA-3710-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ACBD3 | SNV | Missense_Mutation | novel | c.332N>G | p.Lys111Arg | p.K111R | Q9H3P7 | protein_coding | tolerated(0.46) | benign(0.027) | TCGA-AA-3877-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ACBD3 | SNV | Missense_Mutation | c.373A>C | p.Asn125His | p.N125H | Q9H3P7 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
ACBD3 | SNV | Missense_Mutation | novel | c.1529N>G | p.Asn510Ser | p.N510S | Q9H3P7 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |